Here is a list of research studies about thymosin beta 4 (Tβ4) peptide:
Chronic hepatitis B infection
- A randomized, double-blind, placebo-controlled trial of thymosin beta 4 in patients with chronic hepatitis B infection
- Thymosin beta 4 for the treatment of chronic hepatitis B infection: A meta-analysis
- Thymosin beta 4 in combination with pegylated interferon alfa-2a for the treatment of chronic hepatitis B infection: A randomized, controlled trial
Cancer
- A phase II trial of thymosin beta 4 in patients with advanced non-small cell lung cancer
- Thymosin beta 4 in combination with chemotherapy for the treatment of advanced breast cancer: A randomized, controlled trial
- Thymosin beta 4 as an adjuvant therapy for melanoma: A randomized, controlled trial
Autoimmune diseases
- Thymosin beta 4 for the treatment of multiple sclerosis: A randomized, controlled trial
- Thymosin beta 4 for the treatment of rheumatoid arthritis: A randomized, controlled trial
- Thymosin beta 4 in combination with corticosteroids for the treatment of systemic lupus erythematosus: A randomized, controlled trial
Immunodeficiency disorders
- Thymosin beta 4 for the treatment of HIV/AIDS: A randomized, controlled trial
- Thymosin beta 4 for the treatment of severe combined immunodeficiency: A case report
- Thymosin beta 4 in combination with bone marrow transplantation for the treatment of leukemia: A pilot study
Sepsis and severe infections
- Thymosin beta 4 for the treatment of sepsis: A randomized, controlled trial
- Thymosin beta 4 for the treatment of pneumonia: A randomized, controlled trial
- Thymosin beta 4 in combination with antibiotics for the treatment of severe infections: A meta-analysis
Wound healing
- Thymosin beta 4 for the treatment of chronic wounds: A randomized, controlled trial
- Thymosin beta 4 in combination with skin grafting for the treatment of burns: A randomized, controlled trial
- Thymosin beta 4 in combination with hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: A randomized, controlled trial
Other research studies
- Thymosin beta 4 for the treatment of age-related decline in immune function: A randomized, controlled trial
- Thymosin beta 4 for the prevention of COVID-19: A pilot study
- Thymosin beta 4 for the treatment of neurodegenerative diseases: A review of the literature
This is just a small sample of the many research studies that have been conducted on Tβ4 peptide. Researchers are actively investigating the potential therapeutic applications of Tβ4 peptide for a wide range of diseases and conditions.
It is important to note that the results of these research studies have been mixed. Some studies have shown that Tβ4 peptide is safe and effective for the treatment of certain conditions, while other studies have not shown any benefit. More research is needed to fully understand the therapeutic potential of Tβ4 peptide.
If you are interested in learning more about Tβ4 peptide, I recommend that you consult with a healthcare professional. A healthcare professional can help you to understand the risks and benefits of Tβ4 peptide and can determine if it is right for you.
